International Conference on Nephrotoxicity and Drug Safety

This session will explore the underlying biological mechanisms that contribute to nephrotoxicity. Presentations will focus on cellular pathways, molecular interactions, and genetic factors involved in drug-induced kidney injury.

This track will address the clinical methodologies for assessing renal toxicity in patients. Discussions will include biomarkers, imaging techniques, and the role of clinical trials in evaluating kidney safety.

This session will highlight innovative pharmacological strategies aimed at protecting the kidneys from drug-induced damage. Researchers will present findings on nephroprotective agents and their mechanisms of action.

This track will showcase cutting-edge research in nephrology, focusing on novel therapeutic targets and drug development. Participants will engage with the latest findings that have the potential to transform kidney disease management.

This session will discuss the regulatory frameworks governing drug safety assessments related to nephrotoxicity. Experts will provide insights into the challenges and advancements in regulatory science for renal safety.

This track will emphasize the importance of patient engagement in nephrology research and drug safety. Presentations will explore strategies for involving patients in clinical trials and decision-making processes.

This session will delve into the latest advancements in renal pharmacology, focusing on drug interactions and their implications for kidney function. Discussions will also address the challenges faced in the development of renal-safe medications.

This track will focus on the identification and validation of biomarkers for the early detection of nephrotoxicity. Researchers will present their findings on novel biomarkers that can improve patient outcomes.

This session will examine the long-term effects of drug-induced kidney injury on patient health. Presentations will discuss the implications for chronic kidney disease and strategies for monitoring affected individuals.

This track will explore the role of innovative technologies in nephrology, including artificial intelligence and machine learning applications. Researchers will discuss how these technologies can enhance drug safety and kidney health monitoring.

This session will provide a global overview of nephrotoxicity and drug safety practices across different healthcare systems. Experts will share insights on international collaborations and best practices in managing renal toxicity.